[1]
Silva, G.C. et al. 2026. 512 - DESCRIPTIVE EPIDEMIOLOGICAL PROFILE OF PATIENTS WITH HER2-POSITIVE METASTATIC BREAST CANCER SUBMITTED TO PERTUZUMAB AND TRASTUZUMAB AT THE CANCER HOSPITAL OF PERNAMBUCO . Mastology. 32, suppl.1 (Mar. 2026). DOI:https://doi.org/10.29289/259453942022V32S1024.